Company Monitoring Page for Genentech

latest headlines for company on cafepharma

Genentech says Lucentis gets new FDA approval
Yahoo/AP
Wed, 06/23/10 - 09:14 am
Tags:
FDA, Genentech, Lucentis, macular edema
A.M. Vitals: Using Cheaper Genentech Eye Drug Could Save $500 Million a Year
WSJ
Thu, 06/17/10 - 09:46 am
Tags:
Avastin, Genentech, Lucentis, macular degeneration
Regeneron’s $2 Billion Research Push Mimics Genentech
Bloomberg
Wed, 06/9/10 - 08:11 am
Tags:
Regeneron, R&D, Genentech
Rituxan, Revlimid win in maintenance trials
Fierce Pharma
Fri, 05/21/10 - 11:26 am
Tags:
Rituxan, Revlimid, Genentech, clinical trials, lymphoma, Roche, Biogen Idec
US warns Roche, Shire on misleading drug promotions
Reuters
Thu, 05/6/10 - 08:55 am
Tags:
Shire, Roche, FDA, warnings, Genentech, Rituxan, Lialda, Pentasa
New licensing chiefs for AZ, Genentech talk deal strategy
Fierce Biotech
Thu, 05/6/10 - 08:52 am
Tags:
Genentech, licensing, AstraZeneca, BIO
Will Biosimilars Alter Biotech Landscape?
Seeking Alpha
Tue, 05/4/10 - 10:47 am
Tags:
biotech, biosimilars, FDA, Amgen, Genentech, Genzyme
PDL BioPharma: A Genentech/Roche Buyout Candidate?
Seeking Alpha
Sun, 05/2/10 - 11:12 am
Tags:
Genentech, Roche, PDL Biopharma
A Genentech Eye Treatment Is Found to Help Prevent Vision Loss in Diabetics
NY Times, NY
Wed, 04/28/10 - 10:55 am
Tags:
Lucentis, diabetes, Genentech
Biotech's Big Day: The Industry Is Finally Profitable, Mostly Thanks to Cost-Cutting -- Not Higher Sales
BNET Pharma
Wed, 04/28/10 - 07:41 am
Tags:
earnings, biotech, Roche, Genentech
Hope For Muscular Dystrophy Patients?
Forbes
Sat, 02/27/10 - 11:13 am
Tags:
Duchenne Muscular Dystrophy, PTC Therapeutics, Genentech, ataluren
Chugai Pharma to develop & commercialize cancer drug GDC-0449 in Japan
Pharmabiz
Sat, 02/20/10 - 11:48 am
Tags:
Chugai, Curis, Genentech, colorectal cancer, ovarian cancer
Biogen drug OK'd for leukemia treatment
bizjournals.com
Sat, 02/20/10 - 11:01 am
Tags:
Biogen Idec, Rituxan, Genentech, leukemia
7 Reasons Curis Is Worth the Risk
Seeking Alpha
Fri, 02/19/10 - 09:25 am
Tags:
Curis, Genentech, CompuGen, Cepheid
Roche Second-Half Profit Rises on Genentech Savings
Bloomberg
Wed, 02/3/10 - 07:47 am
Tags:
Roche, Genentech, earnings
Digging Deeper into Adventrx Pharmaceuticals
TheStreet.com
Tue, 01/19/10 - 09:39 am
Tags:
Adventrx, Genentech, Novartis, Amgen, Pfizer, Novelos Therapeutics, ONYX Pharmaceuticals
FDA Extends Review Period for Tarceva Application for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer
Yahoo/BusinessWire
Sat, 01/16/10 - 11:07 am
Tags:
Tarceva, OSI Pharmaceuticals, Genentech, Roche
Notes From JP Morgan: Rochentech
InVivo
Tue, 01/12/10 - 10:09 am
Tags:
Roche, Genentech, biotech
Roche, Genentech try to calm jittery partners
Fierce Biotech
Tue, 12/22/09 - 08:06 am
Tags:
Roche, Genentech, M&A
Panel Rejects Early Use of Tarceva
WSJ Online
Wed, 12/16/09 - 10:10 pm
Tags:
Tarceva, OSI Pharmaceuticals, FDA, lung cancer, Roche, Genentech

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.